AI-Assisted Insulin Titration System on Inpatients Glucose Control
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-labeled, parallel group, randomized controlled trial to access
the effect and safety of the Artificial Intelligence Assisted Insulin Titration System
(iNCDSS) in patients with Type 2 Diabetes Mellitus.